Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.22.1
Shareholders' Deficit (Tables)
3 Months Ended
Mar. 31, 2022
Stockholders' Equity Note [Abstract]
Schedule of activity related to non-vested shares
Number of
Non-Vested
Shares
Weighted
Average
Grant Date
Fair Value
Non-vested, December 31, 2021 14,270,120 $ 0.14
Granted
-
-
Forfeited
-
-
Shares vested
-
-
Non-vested, March 31, 2022 14,270,120 $ 0.14

Schedule of stock option activities
Number of
Options
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Balance Outstanding, December 31, 2021 8,445,698 $ 0.40 4.4 $ 0
Exercised
-
-
-
-
Balance Outstanding, March 31, 2022 8,445,698 $ 0.40 4.2 $ 0
Exercisable, March 31, 2022 8,445,698 $ 0.40 4.2 $ 0

Schedule of warrant activities
Number of
Warrants
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Balance Outstanding December 31, 2021 17,500,000 $ 0.05 4.67 $
-
Granted
-
-
-
-
Exercised
-
-
-
-
Balance Outstanding March 31, 2022 17,500,000 $ 0.05 4.42 $
-
Exercisable, March 31, 2022 17,500,000 $ 0.05 4.42 $
-